Aselizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aselizumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target CD62L
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 NYesY (what is this?)  (verify)

Aselizumab is an immunosuppressive drug which has been investigated for the use in severely injured patients. It binds to CD62L.[1]

References[edit]

  1. ^ Seekamp, A; Van Griensven, M; Dhondt, E; Diefenbeck, M; Demeyer, I; Vundelinckx, G; Haas, N; Schaechinger, U; et al. (2004). "The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial". Critical Care Medicine. 32 (10): 2021–8. PMID 15483410. doi:10.1097/01.CCM.0000142396.59236.F3.